[Drug surveillance of beta-blockers in eyedrops].
Vinti
H
H
Taillan
B
B
Chichmanian
R M
RM
Fuzibet
J G
JG
Pesce
A
A
Cassuto
J P
JP
Dujardin
P
P
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D009883:Ophthalmic Solutions; D011358:Product Surveillance, Postmarketing
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions
Pharmacovigilance des bétabloqueurs en collyres.